echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Regarding the public solicitation of "Nano-pharmaceutical quality control research technical guidelines (trial)", "Nano-medicine non-clinical safety evaluation research technical guidelines (trial)", "Nano-medicine non-clinical pharmacokinetic research technical guidelines (trial)" announcement of

    Regarding the public solicitation of "Nano-pharmaceutical quality control research technical guidelines (trial)", "Nano-medicine non-clinical safety evaluation research technical guidelines (trial)", "Nano-medicine non-clinical pharmacokinetic research technical guidelines (trial)" announcement of

    • Last Update: 2021-04-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In recent years, with the development of nanotechnology, nanomedicine research has gradually become one of the hot spots of drug development.


    March 31, 2021


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.